Keyphrases
COVID-19
57%
SARS-CoV-2 Omicron
48%
BA.1
36%
Interferon-α (IFN-α)
35%
E3 Ligase
32%
FBXW7
32%
Somatostatin
32%
Hamster
28%
BA.2
26%
Therapeutic Monoclonal Antibody
25%
Monoclonal Antibody
25%
Apoptosis
22%
SARS-CoV-2 Infection
21%
Inhibin
21%
Antiviral Activity
21%
Omicron Lineages
20%
Antiviral Response
19%
Fc Effector Function
19%
DNA Vaccine
19%
Virus
18%
Antibiotic-free Plasmid
16%
Salmonella Choleraesuis
16%
Bovine Granulosa Cells
16%
Buffalos
16%
RSV Infection
16%
7DW8-5
16%
Retinoic Acid-inducible Gene I (RIG-I)
16%
COPA Syndrome
16%
Mouse Sertoli Cells
16%
Omicron Infection
16%
Antiviral Susceptibility
16%
Broadly Reactive Antibody
16%
Follistatin
16%
Stimulator of Interferon Genes (STING)
16%
Interferon lambda (IFN-λ)
16%
Estradiol
16%
Resilience
16%
Tissue Plasminogen Activator (t-PA)
16%
MRNA Vaccine
16%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
16%
Cell Apoptosis
16%
Influenza-like Illness
16%
N-terminal Domain
16%
Oligoadenylate Synthetase
16%
RNA Interference
16%
AZD7442
16%
Sigma Phase
16%
Aspartate Semialdehyde Dehydrogenase
16%
Interferon Production
16%
Spermatogonial Stem Cells
16%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
89%
Omicron Coronavirus Variant
48%
Monoclonal Antibody
47%
Lineages
28%
Spike
27%
Neutralizing Antibody
27%
interferon
23%
Immunology
21%
DNA Immunization
20%
COVID-19
19%
Respiratory Syncytial Virus
18%
Salmonella Enterica Serovar Choleraesuis
16%
Influenza
16%
Amino Terminal Sequence
16%
Immune Dysregulation
16%
Systemic Lupus Erythematosus
16%
Antiviral Susceptibility
16%
RIG-I
16%
Granulosa Cell
16%
Plasmid
16%
RNA Interference
16%
Cell Cycle
16%
Pathogenicity
16%
Activin
13%
B Cell
12%
Viral Disease
11%
Information Retrieval
10%
Cytokine
9%
Neutralization
9%
Receptor Binding
8%
Ubiquitination
7%
Viral Load
7%
Upregulation
6%
Downregulation
6%
Antigen-Presenting Cell
5%
Cytotoxic T-Cell
5%
Homeostasis
5%
Myeloid
5%
Chemokine
5%
Epitope
5%
Human Respiratory Syncytial Virus
5%
Natural Killer T Cell
5%
Human Monoclonal Antibody
5%
Influenza Virus
5%
Innate Immune System
5%
Missense Mutation
5%
Immunity
5%
Electroporation
5%
Recombinant Plasmid
5%
Kunming Mouse
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Infection
71%
Monoclonal Antibody
42%
Antivirus Agent
24%
Neutralizing Antibody
23%
Inhibin
21%
Interferon
21%
Messenger RNA
21%
DNA Immunization
19%
Biodistribution
16%
Aspartate Semialdehyde Dehydrogenase
16%
Salmonella Enterica Serovar Choleraesuis
16%
Ligase
16%
Diethylstilbestrol
16%
Pathogenicity
16%
Carboxamide
16%
Tissue Plasminogen Activator
16%
Somatostatin
16%
Follistatin
16%
Influenza
16%
Disease
16%
Pristane
16%
mRNA Vaccine
16%
Systemic Lupus Erythematosus
16%
Glycolipid
16%
Cytokine
10%
K 18
9%
Virus Infection
9%
Transgenic Mouse
9%
Lung Disease
8%
Vaccine Strain
8%
Lung Infection
6%
Respiratory Tract
5%
CD8 Antigen
5%
Human Respiratory Syncytial Virus
5%
Chemokine
5%
Autoimmune Disease
5%
Influenza Virus
5%
Human Monoclonal Antibody
5%
B Cell Leukemia
5%